bimagrumab semaglutide combination trial Bimagrumab-Semaglutide Achieves Significant Weight Loss While Preserving Muscle Mass Effect of Bimagrumab vs Placebo

No matter where you choose to start, though, you need to make sure your nutrition and workouts are locked in

For pharma marketers, the game has changed: success now depends on combining traditional HCP engagement with innovative digital-first, patient-focused strategies

In a recent study published in the journal Annals of Internal Medicine , a team of researchers from the National Institutes of Health's National Institute on Drug Abuse and the Case Western Reserve University School of Medicine investigated whether the glucagon-like peptide receptor agonist (GLP-1RA) semaglutide, which has been used to treat obesity and type 2 diabetes mellitus could improve health care measures related to tobacco use disorders

Nemeroff CB

Diabetes Technol Ther 6(1):915

doi: 10.3389/fendo.2021.662582 188 SpaggiariGBriganteGDe VincentisSCattiniURoliLDe SantisMCet al